SABCS 2025 | Pathological characterization of rare tumor types in breast cancer

Sunil Badve • 12 Dec 2025

SABCS 2025

Breast Cancer

Sunil Badve, MD, FRCPath, Emory School of Medicine, Atlanta, GA, describes the challenges of characterizing rare breast cancer tumor types, highlighting the issues of subjectivity in histology-based categorization and the presence of multiple non-targetable mutations. While histology is commonly used for categorization, it can be subjective, and combining clinical data, immunohistochemistry, molecular tools, and artificial intelligence (AI) can help decrease subjectivity and improve diagnosis. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) 2025 Meeting in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.